期刊文献+

肿瘤标记物在小细胞肺癌诊断中的临床价值 被引量:8

Clinical value of tumor markers in diagnosis of small cell lung cancer
原文传递
导出
摘要 小细胞肺癌是一种未分化、恶性程度高、预后较差的特殊肿瘤,因此早期诊断、早期治疗至关重要。本文总结了目前在小细胞肺癌诊断中常用的各类肿瘤标记物,并就其临床应用作一综述。 Small cell lung cancer is an especially species tumor of undifferentiation,high malignancy and poor prognosis. So early diagnosis and early treatment are of significant value. This paper reviews all kinds of tumor markers often used in the diagnosis of small cell lung cancer, and investigates the clinical value of tumor markers.
出处 《国际呼吸杂志》 2009年第14期891-894,共4页 International Journal of Respiration
关键词 肿瘤标记物 小细胞肺癌 诊断 胃泌素释放肽前体 血清神经元特异烯醇化酶 CD56 血管 内皮生长因子 Tumor markers Small cell lung cancer Pro-gastrin-releasing peptide Neuron specific enolase CD56 Vascular endothelial growth factor
  • 相关文献

参考文献24

  • 1邹雄.肿瘤标志在肿瘤早期诊断中的研究与应用进展[J].中华检验医学杂志,2002,25(2):71-72. 被引量:97
  • 2Cuttitta F,Carney DN,Mulshine J,et al.Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.Nature,1985,316:823-826.
  • 3Miyake Y,Kodama T,Yamaguchi K.Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma.Cancer Res,1994,54:2136-2140.
  • 4久保田馨.胃泌素释放肽前体在小细胞肺癌诊断中的价值[J].日本医学介绍,1994,16(12):561-561.
  • 5Stieber P,Dienemann H,Schalhorn A,et al.Pro-gastrin-releasing peptide (ProGRP)-a useful marker in small cell lung carcinomas.Anticancer Res,1999:2673-2678.
  • 6DeGiorgio CM,Gott PS,Rabinowicz At.,et al.Neuronspecific enolase,a marker of acute neuronal injury,is increased in complex partial status epilepticus.Epilepaia,1996,37:606-609.
  • 7厉为良,钱桂生,黄桂君,吴国明.人肺癌组织细胞Na^+/H^+交换蛋白-1基因的表达与其抗凋亡的关系[J].中国癌症杂志,2000,10(2):147-149. 被引量:4
  • 8Ehert W,Hug G,Stabrey A,et al.Evaluation of tumor markers NSE and CEA for the diagnosis and follow-up small cell lung Cancer.Arztl Lab,1989,35; 1-10.
  • 9刘宏新,陈达强.胸水与血清铁蛋白测定对恶性胸水诊断的价值[J].临床荟萃,1997,12(4):179-180. 被引量:16
  • 10Shibayama T,Ueoka H,Nishii K,et al.Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).Lung Cancer,2001,32:61-69.

二级参考文献40

  • 1Rimer BK 徐从高等(译).肿瘤筛查.癌-肿瘤学原理和实践[M].济南:山东科技出版社,2001.653-667.
  • 2厉为良,黄桂君.以肿瘤细胞pH调节机制为靶点的抗癌策略[J].国外医学(肿瘤学分册),1997,24(2):73-75. 被引量:4
  • 3Ebert W, Muley T, Trainer C et al. Comparision of changes in the NSE levlels with clinical assessment in the therapy monitoring of patients with SCLC[J]. Auticancer Res,2002,22(28) :1083.
  • 4Shibayama T,Veoka H,Hishiik et al.Complementary roles of pro - gastrin - releasing peptide(proGRP)and nearon specific enolase(NSE)in diagnosis and prognosis of small - cell lung cancer (SCLC)[J]. Luns Cancer,2001 ,32(1) :61.
  • 5Giovanella L, CerianiL, Bandera M, et al. Immunoraiometric assay of chromogranin A in the diagnosis of small cell lung cancer: Comperative evaluation with neuron - specific enolase[J]. Int J Biol Markers,2001,16(1) :50.
  • 6Bonner JA, Sloan JA, Rowland KM, et al. Significance of neuron - specific enolase levels before and during therapy for small cell lung cancer[J]. Clin Cancer Res,2000,6(2)257.
  • 7Cioffi M,VietriMT.Gazzerrop.et al.Serum anti - p53 antibodies in lung cancer:Comparison with established tumor markers[J].Lung Cancer,2001,33(2-3):163.
  • 8Niho S,Nishiwaki Y,Gotok, et al.Significance of serum pro - gastrin - releasing peptide as a predictor of relapse of small cell lung cancer: Comparative evaluation with neuron - specific enolase and carcinoembryonic antigen[I]. Lung Cancer,2000,27(3) :159.
  • 9Frizazik, Cojean I, PignonJR et al. Normal serum neuron specific enolase(NSE) value after the first cycle of chemotherapy an early predietor of complete response and survival in patients with small cell lung carcinoma[J].Cancer, 1996,82(6) : 1049.
  • 10Shibayama T, Ueoka H, Nishii K, et al. Complementary roles of pro-gastrin-releasing peptide(ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small cell lung cancer(SCLC) [J]. Lung Cancer, 2001,32(1):61-69.

共引文献152

同被引文献65

  • 1康熙雄,陈改清,张国军等.常用临床科研实验室技术及研究策略.北京:现代教育出版社,2010:44-51.
  • 2Wu W,Hu W,Kavanagh JJ.Proteomics in cancer research.Int J Gynecol Cancer,2002,12:409-423.
  • 3Merchant M,Weinberger SR.Recent advancements in surface enhanced laser desorption/ionization-time of flight-mass speetrometry.Electrophoresis,2000,21:1164-1177.
  • 4Fink L,Kohlhoff S,Stein MM,et a1.cDNA array hybridization after laser-assisted microdisseetion from nonneoplastic tissue.Am J Pathol,2002,160:81-90.
  • 5Patricia A,Fetsch MT,Nicole L.Simone,proteomic evaluation of archival cytologic material using SELDE affinity mass spectrometry.Am J Clin Pathol,2002,118:870-876.
  • 6贺艳峰 张家明 郭小英 等.化学发光法检测肿瘤标志物.化学通报,2005,68:135-146.
  • 7张惠娟.标记免疫分析技术的发展及时间分辨荧光免疫技术的临床应用[J].现代中西医结合杂志,2007,16(32):4900-4901. 被引量:7
  • 8王斌,左孟华,梁爽.联合检测胸水细胞p53、p16和K-ras基因突变对于肺癌的诊断价值[J].吉林医学,2007,28(17):1833-1835. 被引量:6
  • 9Torte LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J] CA Cancer J C1in,2015,65(2) :87-108.
  • 10Martinez P,Sales Fidalgo PA,Felip E. Ganitumab for the treat ment of small-cell lung cancer [J]. Expert Opin Investig Drugs, 2014,23(10) :1423-1432.

引证文献8

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部